134 related articles for article (PubMed ID: 15367406)
1. hTERT expression and prognosis in B-chronic lymphocytic leukemia.
Tchirkov A; Chaleteix C; Magnac C; Vasconcelos Y; Davi F; Michel A; Kwiatkowski F; Tournilhac O; Dighiero G; Travade P
Ann Oncol; 2004 Oct; 15(10):1476-80. PubMed ID: 15367406
[TBL] [Abstract][Full Text] [Related]
2. Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome.
Terrin L; Trentin L; Degan M; Corradini I; Bertorelle R; Carli P; Maschio N; Bo MD; Noventa F; Gattei V; Semenzato G; De Rossi A
Leukemia; 2007 May; 21(5):965-72. PubMed ID: 17344921
[TBL] [Abstract][Full Text] [Related]
3. Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia.
Palma M; Parker A; Hojjat-Farsangi M; Forster J; Kokhaei P; Hansson L; Osterborg A; Mellstedt H
Exp Hematol; 2013 Jul; 41(7):615-26. PubMed ID: 23548418
[TBL] [Abstract][Full Text] [Related]
4. Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.
Kokhaei P; Palma M; Hansson L; Osterborg A; Mellstedt H; Choudhury A
Exp Hematol; 2007 Feb; 35(2):297-304. PubMed ID: 17258078
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
[TBL] [Abstract][Full Text] [Related]
6. Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia.
Tobin G; Rosenquist R
Med Oncol; 2005; 22(3):217-28. PubMed ID: 16110132
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.
Marasca R; Maffei R; Morselli M; Zucchini P; Castelli I; Martinelli S; Fontana M; Ravanetti S; Curotti M; Leonardi G; Cagossi K; Partesotti G; Torelli G
J Mol Diagn; 2005 Nov; 7(5):566-74. PubMed ID: 16258154
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
Hara H; Yamashita K; Shinada J; Yoshimura H; Kameya T
Lung Cancer; 2001 Nov; 34(2):219-26. PubMed ID: 11679180
[TBL] [Abstract][Full Text] [Related]
9. Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status.
Kim SZ; Chow KU; Kukoc-Zivojnov N; Boehrer S; Brieger A; Steimle-Grauer SA; Harder L; Hoelzer D; Mitrou PS; Weidmann E
Leuk Lymphoma; 2004 Oct; 45(10):2037-45. PubMed ID: 15370248
[TBL] [Abstract][Full Text] [Related]
10. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia.
Heintel D; Kienle D; Shehata M; Kröber A; Kroemer E; Schwarzinger I; Mitteregger D; Le T; Gleiss A; Mannhalter C; Chott A; Schwarzmeier J; Fonatsch C; Gaiger A; Döhner H; Stilgenbauer S; Jäger U;
Leukemia; 2005 Jul; 19(7):1216-23. PubMed ID: 15858619
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
12. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine.
Abramenko I; Bilous N; Kryachok I; Filonenko I; Pilipenko G; Chumak A; Bazyka D; Bebeshko V
Exp Oncol; 2007 Sep; 29(3):226-30. PubMed ID: 18004251
[TBL] [Abstract][Full Text] [Related]
13. Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia.
Ferrer A; Ollila J; Tobin G; Nagy B; Thunberg U; Aalto Y; Vihinen M; Vilpo J; Rosenquist R; Knuutila S
Cancer Genet Cytogenet; 2004 Aug; 153(1):69-72. PubMed ID: 15325098
[TBL] [Abstract][Full Text] [Related]
14. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery.
Degan M; Bomben R; Bo MD; Zucchetto A; Nanni P; Rupolo M; Steffan A; Attadia V; Ballerini PF; Damiani D; Pucillo C; Poeta GD; Colombatti A; Gattei V
Br J Haematol; 2004 Jul; 126(1):29-42. PubMed ID: 15198729
[TBL] [Abstract][Full Text] [Related]
15. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
Raval A; Lucas DM; Matkovic JJ; Bennett KL; Liyanarachchi S; Young DC; Rassenti L; Kipps TJ; Grever MR; Byrd JC; Plass C
J Clin Oncol; 2005 Jun; 23(17):3877-85. PubMed ID: 15809452
[TBL] [Abstract][Full Text] [Related]
16. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
Tobin G; Thunberg U; Laurell A; Karlsson K; Aleskog A; Willander K; Söderberg O; Merup M; Vilpo J; Hultdin M; Sundström C; Roos G; Rosenquist R
Haematologica; 2005 Apr; 90(4):465-9. PubMed ID: 15820941
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
Stanganelli C; Travella A; Bezares R; Slavutsky I
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
[TBL] [Abstract][Full Text] [Related]
18. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.
Matthews C; Catherwood MA; Morris TC; Kettle PJ; Drake MB; Gilmore WS; Alexander HD
Eur J Haematol; 2006 Oct; 77(4):309-17. PubMed ID: 16856923
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis.
Martinelli S; Maffei R; Castelli I; Santachiara R; Zucchini P; Fontana M; Bonacorsi G; Leonardi G; Marasca R; Torelli G
Leuk Res; 2008 Apr; 32(4):593-7. PubMed ID: 17928052
[TBL] [Abstract][Full Text] [Related]
20. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
